In EAE, selective deletion of S1P1 from astrocytes, but not from neurons, can improve disease severity, demonstrating that astrocytic S1P1 is responsible for the pathogenesis of MS [43]. This evidence concerns the gene S1PR1 and myeloid sarcoma.